InsidersTradesSigma
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
无可用的信号评分。
Explore the full record of transactions filed by Coveney Kevin Michael. Officer active across 1 company, notably Enveric Biosciences, Inc.. In total, 5 disclosures have been recorded. Activity tracked since 13 March 2023. The latest transaction was disclosed on 23 December 2025 (Attribution). Regulator: SEC (Form 4). The full history is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
5 条申报中的 5 条
Kevin Michael Coveney is a declarant linked to Enveric Biosciences, Inc. (XNAS) as Chief Financial Officer. He has 5 filings in total, and across the 5 sampled filings the buy and sell amounts are 0 euro, with filings dated from 2023-03-14 to 2025-12-30.